Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey

Diabetes Res Clin Pract. 2023 Mar:197:110235. doi: 10.1016/j.diabres.2022.110235. Epub 2022 Dec 26.

Abstract

Aims: Social and technical trends are empowering people with diabetes to co-create or self-develop medical devices and treatments to address their unmet healthcare needs, for example, open-source automated insulin delivery (AID) systems. This study aims to investigate the perceived barriers towards adoption and maintaining of open-source AID systems.

Methods: This is a multinational study based on a cross-sectional, retrospective web-based survey of non-users of open-source AID. Participants (n = 129) with type 1 diabetes from 31 countries were recruited online to elicit their perceived barriers towards building and maintaining of an open-source AID system.

Results: Sourcing the necessary components, lack of confidence in one's own technology knowledge and skills, perceived time and energy required to build a system, and fear of losing healthcare provider support appear to be major barriers towards the uptake of open-source AID.

Conclusions: This study identified a range of structural and individual-level barriers to uptake of open-source AID. Some of these individual-level barriers may be overcome over time through the peer support of the DIY online community as well as greater acceptance of open-source innovation among healthcare professionals. The findings have important implications for understanding the possible wider diffusion of open-source diabetes technology solutions in the future.

Keywords: Access and affordability; Artificial pancreas; Automated insulin delivery; Open-source; Type 1 diabetes.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Insulin / therapeutic use
  • Insulins*
  • Retrospective Studies
  • Socioeconomic Factors

Substances

  • Insulins
  • Insulin